8-KThe WireRoutine
Reg FD Disclosure · Company Update
Filed Sep 27, 2022 · 3y ago · Accession 0000950170-22-018864
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- CRISPR Therapeutics AG
- Ticker
- CRSP
- CIK
- 1674416
- Form type
- 8-K
- Filing date
- Sep 27, 2022
- Report date
- Sep 27, 2022
- Document
- crsp-20220927.htm
- Size
- 238 KB